THERAPEUTIC EFFICIENCY OF MEDICATION «VITRUM®VISION FORTE» IN MYOPIA IN TEENAGERS

This paper is designed to report the results of the application of Vitrum Vision Forte (Unipharm Inv., USA) for the treatment of 28 children (56 eyes) at the age from 12 to18 years with mild (n = 15) and moderate (n = 13) myopia (groups 1 and 2 respectively). The treatment enhanced non-corrected distant visual acuity in the patients of group 1 by 17.2% on the average compared with its initial level. Simultaneously, accommodation capacity improved. The absolute accommodation amplitude increased by 2.35 dptr (23.8%) in group 1 and by 1.5 dptr (18.0%) in group 2. The relative accommodation amplitude increased by 1 dptr (15.0%) in children with mild myopia and by 0.9 dptr (13%) in patients with moderate myopia. In both groups results of electrophysiological studies significantly improved. It is concluded that Vitrum Vision Forte can be recommended for a wide application for the treatment of myopia of different degrees in teenagers.

myopia, teenagers, treatment, Vitrum Vision Forte